Testing women for HPV first to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer a year in England.
Women who have had the human papillomavirus (HPV) vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool.
Today, at the Britain Against Cancer conference, the NHS Cervical Screening Programme announces the introduction of liquid based cytology (LBC) and a change in national policy.